Nigel D Toussaint

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. ncbi Measurement of vascular calcification using CT fistulograms
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
    Nephrol Dial Transplant 22:484-90. 2007
  2. ncbi Vascular calcification and arterial stiffness in chronic kidney disease: implications and management
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia
    Nephrology (Carlton) 12:500-9. 2007
  3. ncbi Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
    Nephrol Dial Transplant 23:586-93. 2008
  4. doi Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Nephrology (Carlton) 14:105-12. 2009
  5. doi Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Am J Kidney Dis 56:57-68. 2010
  6. ncbi Using vertebral bone densitometry to determine aortic calcification in patients with chronic kidney disease
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, VIC 3168, Australia
    Nephrology (Carlton) 15:575-83. 2010
  7. doi Review: differences in prescription between conventional and alternative haemodialysis
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia
    Nephrology (Carlton) 15:399-405. 2010
  8. doi A rational guide to reducing fracture risk in dialysis patients
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre and Monash University, Clayton, Vic, Australia
    Semin Dial 23:43-54. 2010
  9. doi Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Clin J Am Soc Nephrol 4:221-33. 2009
  10. pmc Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Clin J Am Soc Nephrol 4:119-27. 2009

Detail Information

Publications21

  1. ncbi Measurement of vascular calcification using CT fistulograms
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
    Nephrol Dial Transplant 22:484-90. 2007
    ..No study to date has combined the CT fistulogram with concurrent determination of VC...
  2. ncbi Vascular calcification and arterial stiffness in chronic kidney disease: implications and management
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia
    Nephrology (Carlton) 12:500-9. 2007
    ..The use of bisphosphonates, calcimimetics, vitamin D therapy and newer experimental treatments, as well as nocturnal dialysis, may have potential benefit...
  3. ncbi Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
    Nephrol Dial Transplant 23:586-93. 2008
    ..Few studies have addressed the extent of VC in the pre-dialysis CKD population, with associated measurements of BMD and arterial compliance...
  4. doi Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Nephrology (Carlton) 14:105-12. 2009
    ..Few studies have correlated VC in the dialysis population with measurements of BMD and arterial compliance...
  5. doi Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Am J Kidney Dis 56:57-68. 2010
    ..Recent studies of hemodialysis patients also suggest benefits of bisphosphonates on vascular calcification; however, no study exists in nondialysis patients with CKD...
  6. ncbi Using vertebral bone densitometry to determine aortic calcification in patients with chronic kidney disease
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, VIC 3168, Australia
    Nephrology (Carlton) 15:575-83. 2010
    ..VC is inversely correlated with bone mineral density (BMD). Screening for VC may be useful to determine those at greater CV risk and dual-energy X-ray absorptiometry (DXA) may have a dual role in providing VC measurement as well as BMD...
  7. doi Review: differences in prescription between conventional and alternative haemodialysis
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, Australia
    Nephrology (Carlton) 15:399-405. 2010
    ..An international quotidian dialysis registry has also recently been created to capture observational data on patients receiving alternative HD regimens and provides further information on dialysis prescriptions for these therapies...
  8. doi A rational guide to reducing fracture risk in dialysis patients
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre and Monash University, Clayton, Vic, Australia
    Semin Dial 23:43-54. 2010
    ..This review outlines available evidence on the incidence, risk factors, and management of fractures in CKD-5D with recommendations for strategies to reduce fracture risk...
  9. doi Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Clin J Am Soc Nephrol 4:221-33. 2009
    ..The authors review the potential benefits and risks associated with bisphosphonate use for bone protection in CKD, and assess their effect on vascular calcification and atherosclerosis...
  10. pmc Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Clin J Am Soc Nephrol 4:119-27. 2009
    ..The aim of this study was to determine measurement of VC using dual-energy x-ray absorptiometry (DXA) with correlation to gold standard computed tomography (CT)...
  11. doi Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Hemodial Int 12:254-63. 2008
    ....
  12. ncbi Comparison between different dialysate calcium concentrations in nocturnal hemodialysis
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia, and Department of Renal Medicine, Geelong Hospital, Geelong, Victoria, Australia
    Hemodial Int 11:217-24. 2007
    ..With concerns that prolonged higher Ca levels contribute to increased cardiovascular mortality, the optimal Ca dialysate bath is still unknown and further studies addressing bone metabolism with larger NHD numbers are required...
  13. doi Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial
    Nigel D Toussaint
    Departments of Nephrology Radiology, Monash Medical Centre Department of Medicine, Monash University, Clayton, Victoria, Australia
    Nephrology (Carlton) 16:290-8. 2011
    ..Few controlled studies have addressed interventions to reduce VC but non-calcium-based phosphate binders may be beneficial. No published randomized study to date has assessed the effect of lanthanum carbonate (LC) on VC progression...
  14. doi Lateral lumbar X-ray assessment of abdominal aortic calcification in Australian haemodialysis patients
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Nephrology (Carlton) 16:389-95. 2011
    ..Using simple radiological imaging we aimed to assess AAC and determine associations in prevalent Australian haemodialysis (HD) patients...
  15. doi Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications
    Matthew J Damasiewicz
    Department of Nephrology, Monash Medical Centre, Monash University, Clayton, Victoria, Australia
    Nephrology (Carlton) 16:261-8. 2011
    ..The discovery of FGF-23 has provided a profound new insight into bone and mineral metabolism, and it may become an important biomarker and therapeutic target in CKD...
  16. ncbi Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure
    Edward R Smith
    Department of Renal Medicine, Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences Monash University, Melbourne, Victoria, Australia
    Nephrology (Carlton) 18:215-21. 2013
    ..The aim of this study was to examine the effects of inflammation, renal function and dialysis modality on serum Fet-A and CPP...
  17. doi Extracellular matrix calcification in chronic kidney disease
    Nigel D Toussaint
    Department of Nephrology, The Royal Melbourne Hospital, Parkville, Australia bDepartment of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Curr Opin Nephrol Hypertens 20:360-8. 2011
    ..This review outlines new findings on calcification at the level of the ECM, with a focus on recent studies evaluating the pathogenesis of calcification of the vasculature...
  18. doi Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice
    Nigel D Toussaint
    Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
    Nephrol Dial Transplant 26:1319-26. 2011
    ..We aimed to determine potential barriers by surveying HD patients and staff about awareness and management of CKD-MBD...
  19. ncbi The importance of klotho in phosphate metabolism and kidney disease
    Sven Jean Tan
    Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia Department of Medicine RMH, The University of Melbourne, Melbourne, Victoria, Australia
    Nephrology (Carlton) 19:439-49. 2014
    ..This review outlines our current understanding of klotho, and its potential contribution to kidney disease and cardiovascular health. ..
  20. doi Low-dose valaciclovir and cytomegalovirus immunoglobulin to prevent cytomegalovirus disease in high-risk renal transplant recipients
    Nigel D Toussaint
    Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia
    Nephrology (Carlton) 16:113-7. 2011
    ..We assessed the efficacy of low-dose valaciclovir (3 months) and intravenous CMV immunoglobulin in the prevention of CMV disease in CMV-negative recipients of kidneys from CMV-positive donors (D+/R-)...
  21. ncbi Calculating glomerular filtration rate in a young man with a large muscle mass
    Nigel D Toussaint
    Department of Renal Medicine, The Geelong Hospital, Geelong, Victoria, Australia
    Med J Aust 185:221-2. 2006